Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Credit Suisse Upgrades Lanxess to Outperform

Credit Suisse upgrades Lanxess (OTC:LNXSF) from Neutral to Outperform.

byBenzinga Newsdesk

September 15, 2021

1 minute read

Credit Suisse upgrades Lanxess (OTC:LNXSF) from Neutral to Outperform.

Wells Fargo Initiates Coverage On Cintas with Equal-Weight Rating, Announces Price Target of $393

By Benzinga Newsdesk

Today, 7:29 AM

Wells Fargo analyst Seth Weber initiates coverage on Cintas (NASDAQ:CTAS) with a Equal-Weight rating and announces Price Target of $393.

CTAS

EMA Says Heart Inflammation Likely Linked To mRNA-Based COVID-19 Vaccines

By Vandana Singh

Today, 7:29 AM

European Medicines Agency (EMA) has established a probable link between heart inflammation and mRNA-based COVID-19 vaccines made by Pfizer Inc (NYSE:PFE) and Moderna…

AZN

Acumen Pharmaceuticals FY21 EPS $(5.02) Up From $(17.48) YoY

By Benzinga Newsdesk

Today, 7:29 AM

Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(5.02) per share. This is a 71.28 percent increase over losses of $(17.48) per share from the same period last year.

ABOS